.

Clinical Experience

 

 

 

22/12/2010
Actualización sobre Medicina Transfusional Perinatal.

 

Medicina Transfusional Perinatal - Prof. Dr. Jorge Decaro

Actualización diagnóstica y terapéutica.

 

Prevención de la inmunización anti –RhD en la gestación y transfusión de hemocomponentes Jorge Decaro

October /2011
Clinical Experience With Filgen JP
 
Movilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience

June /2008
Evaluation Of Bioequivalence Of Mycophenolate Mofetil (12 Healthy Volunteers).
 
Evaluation of Bioequivalence of a new Mycophenolate Mofetil pharmaceutical formulation

June /2008
Mycophenolate Mofetil (24 Healthy Volunteers).
 
Bioequivalence Evaluation of Mycophenolate Mofetil 500 mg Tablets [Suprimun® 500mg (Clausen) vs. CellCept® 500mg (Roche)] in Healthy Volunteers.

01/02/2011
Bioequivalence Study Of Suprimun/Micoflavin/Myclausen In 44 Healthy Volunteers.
 
A Four-Period, Two-Sequence, Replicate Crossover, Open-Label, Single-Dose, Fasting, Bioequivalence Study of Mycophenolate Mofetil* 500 mg Tablets (Laboratorios Clausen S.A.) versus CellCept 500 mg Tablets (Roche) in Normal, Healthy, Non-Smoking Male Subjects. *Suprimun/Micoflavin in Latinamerica Myclausen in the European Union.

2010
Premio el país de la Academia Nacional de Medicina 2010
 
Premio El País de la Academia Nacional de Medicina 2010 Historia de la Medicina Transfusional

December 2006
Evaluation of Filgen JP
 
Evaluation of Haematopoietic stem cells mobilization for autologous bone marrow transplantation in hematological malignancies and solid tumors with Filgen JP (Clausen Filgrastim). Experience of one center (Maciel Hospital, Montevideo Uruguay).

October 2007
Evaluation of Eritrogen
 
Evaluation of Eritrogen (Clausen alfa Erythropoietin - Iclos Erythropoietin) in the treatment of anemia in patients with chronic renal failure in dialysis. Uruguay 2006.

December 2007
Evaluation df Filgen JP
 
Evaluation of Filgen JP (Filgrastim Clausen) for the prevention or treatment of neutropenia induced by chemotherapy in solid tumors treatment.